COSENTYX Trademark

Trademark Overview

On Monday, August 24, 2015, a trademark application was filed for COSENTYX with the United States Patent and Trademark Office. The USPTO has given the COSENTYX trademark a serial number of 86734365. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, November 21, 2025. This trademark is owned by Novartis AG. The COSENTYX trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in rheumatology
cosentyx

General Information

Serial Number86734365
Word MarkCOSENTYX
Filing DateMonday, August 24, 2015
Status800 - REGISTERED AND RENEWED
Status DateFriday, November 21, 2025
Registration Number4979935
Registration DateTuesday, June 14, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2015

Trademark Statements

Goods and ServicesAnti-inflammatories; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in rheumatology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 27, 2015
Primary Code005
First Use Anywhere DateFriday, January 15, 2016
First Use In Commerce DateFriday, January 15, 2016

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Thursday, August 27, 2015NEW APPLICATION ENTERED
Thursday, August 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 19, 2015ASSIGNED TO EXAMINER
Tuesday, October 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 24, 2015PUBLISHED FOR OPPOSITION
Tuesday, November 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2015EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, February 8, 2016EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 22, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2016TEAS STATEMENT OF USE RECEIVED
Monday, April 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 22, 2016USE AMENDMENT FILED
Thursday, April 28, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 11, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 12, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 14, 2016REGISTERED-PRINCIPAL REGISTER
Monday, June 14, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 11, 2021TEAS SECTION 8 & 15 RECEIVED
Saturday, May 7, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 7, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 7, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 14, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 8, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, November 21, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 21, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, November 21, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, November 21, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

cosentyx preparations pharmaceutical system disorders diseases treatment related rheumatology immune autoimmune